Based on 3 analysts offering 12 month price targets for Pharming Group Nv
Min Forecast
$37.00+184.83%
Avg Forecast
$38.33+195.1%
Max Forecast
$41.00+215.63%
Should I buy or sell PHAR stock?
Based on 3 analysts offering ratings for Pharming Group Nv.
Strong Buy
Strong Buy
1 analysts 33.33%
Buy
2 analysts 66.67%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although PHAR's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates PHAR as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More
Be the first to know when Wall Street analysts revise their PHAR stock forecasts and price targets.
Is Pharming Group Nv Stock a good buy in 2026, according to Wall Street analysts?
The consensus among 3 Wall Street analysts covering (NASDAQ: PHAR) stock is to Strong Buy PHAR stock.
Out of 3 analysts, 1 (33.33%) are recommending PHAR as a Strong Buy, 2 (66.67%) are recommending PHAR as a Buy, 0 (0%) are recommending PHAR as a Hold, 0 (0%) are recommending PHAR as a Sell, and 0 (0%) are recommending PHAR as a Strong Sell.
According to 3 Wall Street analysts that have issued a 1 year PHAR price target, the average PHAR price target is $38.33, with the highest PHAR stock price forecast at $41.00 and the lowest PHAR stock price forecast at $37.00.
On average, Wall Street analysts predict that Pharming Group Nv's share price could reach $38.33 by Apr 10, 2027. The average Pharming Group Nv stock price prediction forecasts a potential upside of 195.1% from the current PHAR share price of $12.99.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.